Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Inhibition of CRISPR-Cas9 with Bacteriophage Proteins
Benjamin J. Rauch
, Melanie R. Silvis
, Judd F. Hultquist
, Christopher S. Waters
, Michael J. McGregor
, Nevan J. Krogan
, Joseph Bondy-Denomy
Research output
:
Contribution to journal
›
Article
›
peer-review
403
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of CRISPR-Cas9 with Bacteriophage Proteins'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cas9 Protein
100%
Bacteriophage Proteins
100%
CRISPR-Cas System
50%
Listeria Monocytogenes
50%
Prophage
50%
Human Cells
25%
Genetic Engineering
25%
Sequence Specificity
25%
CRISPR-Cas9 System
25%
Phage
25%
Streptococcus Pyogenes (S. pyogenes)
25%
Inhibitor Protein
25%
Potential Indicators
25%
Escherichia Coli Cells
25%
RNA-guided nuclease
25%
Bacteriophage Infection
25%
Engineering Activities
25%
CRISPR Spacers
25%
Cas9 Inhibitor
25%
CRISPR Activation
25%
Bacterial Genome
25%
CRISPR Inhibition
25%
Immunology and Microbiology
CRISPR/Cas9
100%
Bacteriophage
100%
Clustered Regularly Interspaced Short Palindromic Repeat
60%
Prophage
40%
CRISPR Cas System
40%
Human Cell
20%
Escherichia coli
20%
Infectious Disease
20%
Listeria monocytogenes
20%
Nuclease
20%
Streptococcus pyogenes
20%
Bacterial Genome
20%
Genome Editing
20%
Infection
20%
Ribonucleic Acid
20%